FontsA A
ContrastA A
Newsletter Sign-Up


implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC

Topic: H2020-INFRADEV-3-2015

Type of Action: RIA

Duration: 36 months

Start Date: 1 October 2015

Grant Agreement Nr: 676550

Web: BBMRI-ERIC website

Coordinator: Erik Steinfelder

Total requested Grant by Consortium: €4,950,860.00

Total requested Grant by BBMRI-ERIC: €3,786,840.00
(includes funds for Headquarters, Common Service ELSI, Common Service IT, linked third parties)

Linked Third Parties/BBMRI-ERIC Framework Agreement:;;;

Benefit/tasks for BBMRI-ERIC: Coordinated by BBMRI-ERIC, funding for key activities



The ADOPT BBMRI-ERIC proposal aims at boosting and accelerating implementation of BBMRI-ERIC and its services. Its main deliverables are designed to complete or launch the construction of key Common Services of the Research Infrastructure as required for European Strategy Forum on Research Infrastructure-(ESFRI) -projects ‘under implementation’, reflecting the targets of the European Research Area (ERA). One of the challenges in the post-genomic era is the research on common complex diseases, such as cancer, diabetes and Alzheimer’s disease. Revealing these diseases will depend critically on the study of human biological samples and data from large numbers of patients and healthy individuals. The EU’s ageing population will result in an increase in many of those diseases and consequently an increased healthcare expenditure for senior citizens. Its implementation is essential for the understanding of the diversity of human diseases, biological samples and corresponding data, which are required for the development of any new drug or diagnostic assay and are, therefore, critical for the advancement in health research, ultimately leading to personalised medicine. BBMRI-ERIC will provide a gateway access to the collections of the European research community, expertise and services building on the outcome of ADOPT BBMRI-ERIC.

List of Participants

BBMRI-ERIC incl. linked third parties/(namely MUG on behalf of, THL on behalf of, UoM on behalf of, UNIMIB on behalf of, BELSPO on behalf of, Belgium; SNF on behalf of, Switzerland; MMCI on behalf of, Czech Republic; Charité on behalf of, Germany; UT on behalf of, Estonia; INSERM on behalf of, France; AA on behalf of, Greece; LUMC on behalf of, The Netherlands; NTNU on behalf of, Norway; Kierujący Biobankiem Wrocławskiego Centrum; Badań EIT on behalf of, Poland; KI on behalf of, Sweden; Dokuz Eylul University on behalf of, Turkey; IARC, France; TUM, Germany; IOR, Italy, University College London, United Kingdom


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.

European emblem EU

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies from this website. If you would like to change your preferences you may do so by following the instructions